<SEC-DOCUMENT>0001104659-20-103937.txt : 20200910
<SEC-HEADER>0001104659-20-103937.hdr.sgml : 20200910
<ACCEPTANCE-DATETIME>20200910160524
ACCESSION NUMBER:		0001104659-20-103937
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20200908
FILED AS OF DATE:		20200910
DATE AS OF CHANGE:		20200910

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Waclawski Anthony
		CENTRAL INDEX KEY:			0001823486

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36641
		FILM NUMBER:		201168785

	MAIL ADDRESS:	
		STREET 1:		C/O BRAINSTORM CELL THERAPEUTICS, INC.
		STREET 2:		1325 AVENUE OF THE AMERICAS 28TH FL
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BRAINSTORM CELL THERAPEUTICS INC.
		CENTRAL INDEX KEY:			0001137883
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				207273918
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		1325 AVENUE OF AMERICAS
		STREET 2:		28TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019
		BUSINESS PHONE:		201-488-0460

	MAIL ADDRESS:	
		STREET 1:		1325 AVENUE OF AMERICAS
		STREET 2:		28TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BRAINSTORM CELL THERAPEUTICS INC
		DATE OF NAME CHANGE:	20041122

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GOLDEN HAND RESOURCES INC
		DATE OF NAME CHANGE:	20030827

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WIZBANG TECHNOLOGIES INC
		DATE OF NAME CHANGE:	20010409
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>tm2030582d2_3.xml
<DESCRIPTION>OWNERSHIP DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2020-09-08</periodOfReport>

    <noSecuritiesOwned>1</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001137883</issuerCik>
        <issuerName>BRAINSTORM CELL THERAPEUTICS INC.</issuerName>
        <issuerTradingSymbol>BCLI</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001823486</rptOwnerCik>
            <rptOwnerName>Waclawski Anthony</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O BRAINSTORM CELL THERAPEUTICS INC.</rptOwnerStreet1>
            <rptOwnerStreet2>1325 AVENUE OF THE AMERICAS 28TH FL</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10019</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>See Remarks</officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <remarks>EVP, Global Head of Regulatory Affairs - Exhibit 24 -- Power of Attorney</remarks>

    <ownerSignature>
        <signatureName>/s/ Anthony Waclawski</signatureName>
        <signatureDate>2020-09-10</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>tm2030582d2_ex-24.htm
<DESCRIPTION>EXHIBIT 24
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 24</B></P>

<P STYLE="margin: 0; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">Brainstorm
cell therapeutics inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">LIMITED
Power of Attorney&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This statement confirms that the undersigned
has authorized and designated each of Chaim Lebovits, Uri Yablonka, Mitchell S. Bloom and Jesse Nevarez, as attorneys-in-fact to
(i) prepare, execute and file on behalf of the undersigned Form ID or any other necessary documents or forms in order to obtain
access codes (including, without limitation, CIK and CCC codes) for the undersigned to permit filing on EDGAR, and (ii) prepare,
execute and file on behalf of the undersigned all Forms 3, 4 and 5 (including any amendments thereto) that the undersigned may
be required to file with the U.S. Securities and Exchange Commission as a result of the undersigned's ownership of or transactions
in securities of Brainstorm Cell Therapeutics Inc. The authority of such attorneys under this Power of Attorney shall continue
until the undersigned is no longer required to file Forms 3, 4 and 5 with regard to the undersigned's ownership of or transactions
in securities of Brainstorm Cell Therapeutics Inc., unless earlier revoked in writing. The undersigned acknowledges that such attorneys
are not assuming any of the undersigned's responsibilities to comply with the requirements of Section 16 of the Securities Exchange
Act of 1934, as amended, or any of the undersigned's liabilities for failure to comply with such requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 47%">/s/ Anthony Waclawski</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Date: September 1, 2020</TD>
    <TD>&nbsp;</TD>
    <TD>Name:&nbsp;&nbsp;Anthony Waclawski</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
